Women s health initiative trial of estrogen plus progestin
This presentation is the property of its rightful owner.
Sponsored Links
1 / 3

Women’s Health Initiative: Trial of Estrogen plus Progestin PowerPoint PPT Presentation


  • 56 Views
  • Uploaded on
  • Presentation posted in: General

Women’s Health Initiative: Trial of Estrogen plus Progestin. 16,608 women randomized Conjugated equine estrogens 0.625 mg/d + medroxyprogesterone acetate 2.5 mg/d vs. placebo Primary outcome: nonfatal MI or CHD death Primary adverse outcome: breast cancer

Download Presentation

Women’s Health Initiative: Trial of Estrogen plus Progestin

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Women s health initiative trial of estrogen plus progestin

Women’s Health Initiative: Trial of Estrogen plus Progestin

  • 16,608 women randomized

  • Conjugated equine estrogens 0.625 mg/d + medroxyprogesterone acetate 2.5 mg/d vs. placebo

  • Primary outcome: nonfatal MI or CHD death

  • Primary adverse outcome: breast cancer

  • Stopped early (mean follow-up 5.2 years) because health risks exceeded benefits

Writing Group for the WHI Investigators. JAMA 2002;288:321-333.


Risks and benefits of estrogen progestin on clinical outcomes women s health initiative

Risks and Benefits of Estrogen/Progestin on Clinical Outcomes: Women’s Health Initiative

*1st event: CHD; stroke; pulmonary embolism; breast, endometrial, or colorectal cancer; hip fracture, or death due to other causes

Writing Group for the WHI Investigators. JAMA 2002;288:321-333.


Women s health initiative trial of estrogen plus progestin

Absolute Excess Risks and Absolute Risk Reductions per 10,000 Person-Years: Women’s Health Initiative

Writing Group for the WHI Investigators. JAMA 2002;288:321-333.


  • Login